• FirefoxUpgrade to the new Firefox »
  •  Dow Down0.79% Nasdaq Up0.16%

    BioMarin Pharmaceutical Inc. (BMRN)

    -NMS
    97.69 Up 1.84(1.92%) Jan 23, 4:00PM EST
    |After Hours : 95.85 Down 1.84 (1.88%) Jan 23, 4:16PM EST
    Add to Portfolio
    Cash FlowGet Cash Flow for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Net Income (176,353) (114,347) (53,836)
    Operating Activities, Cash Flows Provided By or Used In
    Depreciation53,044  48,804  39,082  
    Adjustments To Net Income86,759  50,093  58,606  
    Changes In Accounts Receivables(8,756)(4,227)(18,456)
    Changes In Liabilities29,979  43,445  11,733  
    Changes In Inventories(33,910)1,423  (20,420)
    Changes In Other Operating Activities(10,397)(7,582)1,706  
    Total Cash Flow From Operating Activities (59,634) 17,609   18,415  
    Investing Activities, Cash Flows Provided By or Used In
    Capital Expenditures(65,124)(44,571)(73,219)
    Investments(106,399)(144,331)66,562  
    Other Cash flows from Investing Activities(127,260)(6,743)(82,903)
    Total Cash Flows From Investing Activities (298,783) (195,645) (89,560)
    Financing Activities, Cash Flows Provided By or Used In
    Dividends Paid -   -   -  
    Sale Purchase of Stock36,369  316,901  33,592  
    Net Borrowings712,630  (678)(2,775)
    Other Cash Flows from Financing Activities(3,061)(4,405)(1,894)
    Total Cash Flows From Financing Activities 746,671   312,291   29,338  
    Effect Of Exchange Rate Changes -   -   -  
    Change In Cash and Cash Equivalents 388,254   134,255   (41,807)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.